AliveCor said it raised nearly $6 million in equity financing for its mobile electrocardiogram devices.
The Mountain View, Calif.-based company said nine investors put up a collective $5.8 million toward its $9.2 million goal. The first sale was Oct. 15, according to the filing.
AliveCor makes the KardiaBand, a wrist-worn device that is designed to detect atrial fibrillation, and the KardiaMobile app, a clinical-grade monitor that uses fingerpads to generate an ECG. KardiaMobile was cleared by the FDA for detecting bradycardia and tachycardia in April, then won clearance for the KardiaMobile 6L six-lead personal ECG device in May.
The company secured a $20 million loan from investment firm Oxford Finance in January, which was earmarked for working capital as AliveCor looked to expand the footprint of its mobile ECG devices.